Cargando…

Hypoglycaemia and cardiac arrhythmias in diabetes

Hypoglycaemia remains an inevitable risk in insulin-treated type 1 diabetes and type 2 diabetes and has been associated with multiple adverse outcomes. Whether hypoglycaemia is a cause of fatal cardiac arrhythmias in diabetes, or merely a marker of vulnerability, is still unknown. Since a pivotal re...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Andreas, Jørgensen, Peter G., Knop, Filip K., Vilsbøll, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238305/
https://www.ncbi.nlm.nih.gov/pubmed/32489579
http://dx.doi.org/10.1177/2042018820911803
_version_ 1783536512865927168
author Andersen, Andreas
Jørgensen, Peter G.
Knop, Filip K.
Vilsbøll, Tina
author_facet Andersen, Andreas
Jørgensen, Peter G.
Knop, Filip K.
Vilsbøll, Tina
author_sort Andersen, Andreas
collection PubMed
description Hypoglycaemia remains an inevitable risk in insulin-treated type 1 diabetes and type 2 diabetes and has been associated with multiple adverse outcomes. Whether hypoglycaemia is a cause of fatal cardiac arrhythmias in diabetes, or merely a marker of vulnerability, is still unknown. Since a pivotal report in 1991, hypoglycaemia has been suspected to induce cardiac arrhythmias in patients with type 1 diabetes, the so-called ‘dead-in-bed syndrome’. This suspicion has subsequently been supported by the coexistence of an increased mortality and a three-fold increase in severe hypoglycaemia in patients with type 2 diabetes receiving intensive glucose-lowering treatment in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Studies have investigated the association between hypoglycaemia-induced cardiac arrhythmias. In a rat-model, severe hypoglycaemia resulted in a specific pattern of cardiac arrhythmias including QT-prolongation, ventricular tachycardia, second- and third-degree AV block and ultimately cardiorespiratory arrest. In clinical studies of experimentally induced hypoglycaemia, QTc-prolongation, a risk factor of ventricular arrhythmias, is an almost consistent finding. The extent of QT-prolongation seems to be modified by several factors, including antecedent hypoglycaemia, diabetes duration and cardiac autonomic neuropathy. Observational studies indicate diurnal differences in the pattern of electrocardiographic alterations during hypoglycaemia with larger QTc-prolongations during daytime, whereas the risk of bradyarrhythmias may be increased during sleep. Daytime periods of hypoglycaemia are characterized by shorter duration, increased awareness and a larger increase in catecholamines. The counterregulatory response is reduced during nightly episodes of hypoglycaemia, resulting in prolonged periods of hypoglycaemia with multiple nadirs. An initial sympathetic activity at plasma glucose nadir is replaced by increased vagal activity, which results in bradycardia. Here, we provide an overview of the existing literature exploring potential mechanisms for hypoglycaemia-induced cardiac arrhythmias and studies linking hypoglycaemia to cardiac arrhythmias in patients with diabetes.
format Online
Article
Text
id pubmed-7238305
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72383052020-06-01 Hypoglycaemia and cardiac arrhythmias in diabetes Andersen, Andreas Jørgensen, Peter G. Knop, Filip K. Vilsbøll, Tina Ther Adv Endocrinol Metab Review Hypoglycaemia remains an inevitable risk in insulin-treated type 1 diabetes and type 2 diabetes and has been associated with multiple adverse outcomes. Whether hypoglycaemia is a cause of fatal cardiac arrhythmias in diabetes, or merely a marker of vulnerability, is still unknown. Since a pivotal report in 1991, hypoglycaemia has been suspected to induce cardiac arrhythmias in patients with type 1 diabetes, the so-called ‘dead-in-bed syndrome’. This suspicion has subsequently been supported by the coexistence of an increased mortality and a three-fold increase in severe hypoglycaemia in patients with type 2 diabetes receiving intensive glucose-lowering treatment in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Studies have investigated the association between hypoglycaemia-induced cardiac arrhythmias. In a rat-model, severe hypoglycaemia resulted in a specific pattern of cardiac arrhythmias including QT-prolongation, ventricular tachycardia, second- and third-degree AV block and ultimately cardiorespiratory arrest. In clinical studies of experimentally induced hypoglycaemia, QTc-prolongation, a risk factor of ventricular arrhythmias, is an almost consistent finding. The extent of QT-prolongation seems to be modified by several factors, including antecedent hypoglycaemia, diabetes duration and cardiac autonomic neuropathy. Observational studies indicate diurnal differences in the pattern of electrocardiographic alterations during hypoglycaemia with larger QTc-prolongations during daytime, whereas the risk of bradyarrhythmias may be increased during sleep. Daytime periods of hypoglycaemia are characterized by shorter duration, increased awareness and a larger increase in catecholamines. The counterregulatory response is reduced during nightly episodes of hypoglycaemia, resulting in prolonged periods of hypoglycaemia with multiple nadirs. An initial sympathetic activity at plasma glucose nadir is replaced by increased vagal activity, which results in bradycardia. Here, we provide an overview of the existing literature exploring potential mechanisms for hypoglycaemia-induced cardiac arrhythmias and studies linking hypoglycaemia to cardiac arrhythmias in patients with diabetes. SAGE Publications 2020-05-19 /pmc/articles/PMC7238305/ /pubmed/32489579 http://dx.doi.org/10.1177/2042018820911803 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Andersen, Andreas
Jørgensen, Peter G.
Knop, Filip K.
Vilsbøll, Tina
Hypoglycaemia and cardiac arrhythmias in diabetes
title Hypoglycaemia and cardiac arrhythmias in diabetes
title_full Hypoglycaemia and cardiac arrhythmias in diabetes
title_fullStr Hypoglycaemia and cardiac arrhythmias in diabetes
title_full_unstemmed Hypoglycaemia and cardiac arrhythmias in diabetes
title_short Hypoglycaemia and cardiac arrhythmias in diabetes
title_sort hypoglycaemia and cardiac arrhythmias in diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238305/
https://www.ncbi.nlm.nih.gov/pubmed/32489579
http://dx.doi.org/10.1177/2042018820911803
work_keys_str_mv AT andersenandreas hypoglycaemiaandcardiacarrhythmiasindiabetes
AT jørgensenpeterg hypoglycaemiaandcardiacarrhythmiasindiabetes
AT knopfilipk hypoglycaemiaandcardiacarrhythmiasindiabetes
AT vilsbølltina hypoglycaemiaandcardiacarrhythmiasindiabetes